Patent · US Active

Rapid expression cloning of human monoclonal antibodies from memory B cells

US8840890B2 · kind B2 · utility

12Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 12, 2009
Grant dateSep 23, 2014
Priority date—
Expiry dateJan 7, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present application provides methods for producing human monoclonal antibodies without using hybridoma technology, antibodies produced used the described methods, and methods for using the antibodies to treat or prevent disease conditions (e.g., infection by pathogens such as the Human Immunodeficiency Virus).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.